Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Emergency Use Authorization Granted For BioCryst's Peramivir
Reuters
Saturday, October 24, 2009 - 11:10am
tags:
Biocryst, peramivir
Pfizer slaps Unilab with patent suit over contested drug
Inquirer.net
Saturday, October 24, 2009 - 11:08am
tags:
Pfizer, Unilab, Lipitor
Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer
Reuters
Saturday, October 24, 2009 - 11:06am
tags:
Exelixis, Bristol-Myers Squibb
Allergan Announces Victory in Brimonidine Patent Infringement Case
Yahoo/Zacks
Saturday, October 24, 2009 - 11:02am
tags:
Allergan
Alexion Beats, Raises Outlook
Yahoo/Zacks
Saturday, October 24, 2009 - 11:01am
tags:
Alexion
CEPH's Nuvigil Faces Generic Threat
Yahoo/Zacks
Saturday, October 24, 2009 - 10:53am
tags:
NUVIGIL, Cephalon, Provigil
Medicines Co. gets positive EU panel result
Yahoo/AP
Saturday, October 24, 2009 - 10:52am
tags:
Medicines Company, Angiox
Ardea Presents Gout Data
Yahoo/Zacks
Saturday, October 24, 2009 - 10:51am
tags:
Ardea, gout
Pharma Seeks Cure For Off-Label Woes
Yahoo/Investor's Business Daily
Saturday, October 24, 2009 - 10:50am
tags:
off label
I Don't Need No Massive Merger (BMS)
Motley Fool
Saturday, October 24, 2009 - 10:48am
tags:
Bristol-Myers Squibb
Merck-Schering Doesn't Look So Good
Motley Fool
Saturday, October 24, 2009 - 10:48am
tags:
Merck, Schering Plough
Myriad Pharmaceuticals' Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R)
Yahoo/Global News Wire
Saturday, October 24, 2009 - 10:46am
tags:
Myriad, Azixa, Avastin, brain cancer
Not 50% Growth, but We'll Take It (Celgene)
Motley Fool
Saturday, October 24, 2009 - 10:45am
tags:
Celgene, Revlimid
Isis Diabetes Drug Shows Promise
Yahoo/Zacks.com
Friday, October 23, 2009 - 12:00pm
tags:
diabetes, Isis Pharmaceuticals
Dr. Reddy’s Profit Doubles on Sales in U.S., Russia
Bloomberg
Friday, October 23, 2009 - 11:33am
tags:
Dr Reddy's, earnings, India
Biogen, Elan Fall as Tysabri Brain Disease Cases Rise
Bloomberg
Friday, October 23, 2009 - 11:29am
tags:
Tysabri, PML, Elan, Biogen Idec
FDA reviews Human Genome's anthrax medication
Yahoo/AP
Friday, October 23, 2009 - 11:26am
tags:
Human Genome Sciences, anthrax, FDA, ABthrax
Pfizer rejoins pharma stampede to India
Fierce Pharma
Friday, October 23, 2009 - 11:24am
tags:
India, Pfizer
Canadian Judge: Zyprexa Is An ‘Almost Invention’
Pharmalot
Friday, October 23, 2009 - 11:21am
tags:
Eli Lilly, Zyprexa, antipsychotics, Canada
Allergan’s First Amendment Case: REMS vs. Off-Label Promotion – and DTC
InVivo
Friday, October 23, 2009 - 5:29am
tags:
off-label, Allergan, DTC, Botox

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.